This post-hoc analysis of a randomized trial suggested that a counseling intervention that improved quality of life may reduce the risk of major adverse cardiovascular events in people with peripheral artery disease. https://t.co/JZyjzcZaSE
@trisharoymd For IC intervention should be avoided- https://t.co/OAAWJFBsdw
I have a patient who's sister had 4 interventions for IC elsewhere & now being considered for amputation while I have treated her medically.
But this story refers to ischemic ulcers where revascularisation is needed??
We badly need further effective medical and rehabilitation treatments for peripheral artery disease as outlined in this recent review
https://t.co/XlufrQKRQW
During Healthy Skin Month (November 2021), we congratulate Dr. Jonathan Golledge @BloodVesselDoc1@AITropHealthMed of @jcu and Townsville University Hospital --
Recognized as an Expertscape Expert in Foot Ulcers.
https://t.co/mtUhg4NK7q
Hats off to Professor Jonathon Golledge recognised in a special report in The Australian’s research magazine today, as a leader in the health and medical sciences for his work in vascular medicine.
https://t.co/m2h7yPLkdx
Publication of the TEDY trial. Huge thanks to all those who contributed to getting this done including investigators, coordinators and participants
https://t.co/YUImjdZqTH
@AITropHealthMed@stanfordvasc@berniebmb
@ceo_nhmrc @NHMRC this is devastating news. My 19 colleagues and I have been working for 9 months on a Synergy application which was a near miss last round. It is 99% submitted.
@bbctms Dear Andrew
Great condolences to you & family. My wife was diagnosed with alk+ lung cancer (age of 31) and we have noted the limited focus on lung cancer but a real opportunity to advance its treatment (e.g. recent drug advances). Your foundation would be an important advance.